Perceived social support moderates the link between threat-related amygdala reactivity and trait anxiety.
Several lines of research have illustrated that negative environments can precipitate psychopathology, particularly in the context of relatively increased biological risk, while social resources can buffer the effects of these environments. However, little research has examined how social resources might buffer proximal biological risk for psychopathology or the neurobiological pathways through which such buffering may be mediated. Here we report that the expression of trait anxiety as a function of threat-related amygdala reactivity is moderated by perceived social support, a resource for coping with adversity. A significant positive correlation between amygdala reactivity and trait anxiety was evident in individuals reporting below average levels of support but not in those reporting average or above average levels. These results were consistent across multiple measures of trait anxiety and were specific to anxiety in that they did not extend to measures of broad negative or positive affect. Our findings illuminate a biological pathway, namely moderation of amygdala-related anxiety, through which social support may confer resilience to psychopathology. Moreover, our results indicate that links between neural reactivity and behavior are not static but rather may be contingent on social resources.
Hyde
Luke W
LW
Department of Psychology, University of Pittsburgh, Pittsburgh, PA 15260, USA. lwh2@pitt.edu
Gorka
Adam
A
Manuck
Stephen B
SB
Hariri
Ahmad R
AR
D000223:Adaptation, Psychological; D000328:Adult; D000374:Aggression / Q000523:psychology*; D000679:Amygdala / Q000502:physiology*; D001007:Anxiety / Q000523:psychology*; D001931:Brain Mapping; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D012944:Social Support; D013694:Temperament
Neuroimage. 2010 Mar;50(1):184-9
19900563
Science. 2002 Aug 2;297(5582):851-4
12161658
Am J Psychiatry. 1999 Jun;156(6):837-41
10360120
Neuron. 2004 Dec 16;44(6):1043-55
15603746
Neuroimage. 2006 Jun;31(2):934-44
16492400
Psychoneuroendocrinology. 2010 Jan;35(1):94-104
19493626
Psychol Bull. 1985 Sep;98(2):310-57
3901065
Am Psychol. 2001 Mar;56(3):227-38
11315249
Biol Psychiatry. 2010 Sep 1;68(5):416-24
20497902
Am Psychol. 2009 May-Jun;64(4):241-56
19449983
Annu Rev Clin Psychol. 2005;1:293-319
17716090
Biol Psychiatry. 2002 Sep 15;52(6):529-42
12361667
Am Psychol. 1998 Feb;53(2):205-20
9491748
Am J Community Psychol. 1984 Oct;12(5):567-87
6496413
Psychiatry Res. 2008 Jan 15;162(1):51-7
18068954
Mol Psychiatry. 2005 Sep;10(9):884-8, 805
16044172
Am J Psychiatry. 2007 Feb;164(2):318-27
17267796
Neuroreport. 2005 Oct 17;16(15):1671-5
16189475
N Engl J Med. 1991 Aug 29;325(9):606-12
1713648
Biol Psychiatry. 2002 May 1;51(9):693-707
11983183
Nat Neurosci. 2006 Nov;9(11):1362-3
17013380
Cereb Cortex. 2010 Mar;20(3):612-21
19556348
Am J Psychiatry. 2010 May;167(5):509-27
20231323
Biol Psychiatry. 2009 Jul 1;66(1):9-16
19103437
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
3397865
Annu Rev Neurosci. 2009;32:225-47
19400720
Cogn Affect Behav Neurosci. 2005 Jun;5(2):156-68
16180622
Neuropsychopharmacology. 2008 Dec;33(13):3221-5
18463627
Neuropsychopharmacology. 2010 Jan;35(1):192-216
19693001
Cereb Cortex. 2009 Nov;19(11):2499-507
19321655
Arch Gen Psychiatry. 2009 Jan;66(1):33-40
19124686
Science. 2003 Jul 18;301(5631):386-9
12869766
Behav Neurosci. 2007 Apr;121(2):249-56
17469914
J Pers Assess. 1995 Feb;64(1):21-50
16367732
Arch Gen Psychiatry. 1993 Dec;50(12):975-90
8250684
Am J Psychiatry. 2007 Oct;164(10):1613-4
17898358
Am J Psychiatry. 2004 Apr;161(4):631-6
15056508
Biol Psychiatry. 2006 Mar 1;59(5):424-9
16256956
Am J Psychiatry. 2008 Jan;165(1):90-8
17986682
Psychol Bull. 1991 Nov;110(3):406-25
1758917
Ann N Y Acad Sci. 2006 Dec;1094:1-12
17347337